All You Need to Know as an Authorized User

Baldwin, Jon; Bag, Asim K.; White, Sharon; Palot-Manzil, Fathima F.; O’Malley, Janis P.

doi:10.2214/ajr.14.13283

Cited by 5 publications

(6 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To approve a RAM license for the use of radioactive materials in humans, the NRC requires ≥1 AU be named on the license. The AU must be a physician who meets the NRC's training requirements for handling radioactive materials in a medical setting, manages safe material handling, and can supervise others who may need to use radioactive materials for training and other purposes 18 . The AU is typically a nuclear medicine physician, radiologist, or radiation oncologist.…”

Section: Methods and Guidance For Building A Robust Rlt Programmentioning

confidence: 99%

“…Although RSOs are ultimately responsible for the safe use of radioactive materials at an institution, the RSO may form a radiation safety team and designate other individuals to perform specific tasks. The RSO (or designee) maintains accurate records of all RLT doses administered at the center, provides radiation safety training to staff and monitors their exposure using dosimeter badges, prepares the treatment room and patient restroom using contamination control measures, provides radiologic surveys as needed, consults with other providers if a patient undergoing RLT has a medical emergency, and helps ensure that the design and structure of new or remodeled facilities meet radiation safety requirements 18 . The RSO or designee also handles collection, storage, and disposal of radioactive waste.…”

Section: Methods and Guidance For Building A Robust Rlt Programmentioning

confidence: 99%

“…2.1.4 | Radiation safety program and radiation safety officer RAM licensing requires an appropriate radiation safety program for the handling and disposal of radioactive materials. 7,10,19 The RSO is a key participant in this program 18 and is also responsible for ensuring that institutions meet any additional region-specific regulations. Although RSOs are ultimately responsible for the safe use of radioactive materials at an institution, the RSO may form a radiation safety team and designate other individuals to perform specific tasks.…”

Section: Authorized Usermentioning

confidence: 99%

“…The RSO (or designee) maintains accurate records of all RLT doses administered at the center, provides radiation safety training to staff and monitors their exposure using dosimeter badges, prepares the treatment room and patient restroom using contamination control measures, provides radiologic surveys as needed, consults with other providers if a patient undergoing RLT has a medical emergency, and helps ensure that the design and structure of new or remodeled facilities meet radiation safety requirements. 18 The RSO or designee also handles collection, storage, and disposal of radioactive waste. This includes residual or unused doses of radiopharmaceuticals and any contaminated materials generated during therapy.…”

Section: Authorized Usermentioning

confidence: 99%

See 3 more Smart Citations

Establishing a robust radioligand therapy program: A practical approach for North American centers

Mittra,

Wong,

Winters

et al. 2024

Cancer Medicine

View full text Add to dashboard Cite

Radioligand therapy (RLT) is a targeted approach to treating cancer that has been shown to be safe and effective in a variety of disease states, including gastroenteropancreatic neuroendocrine tumors, lymphoma, and most recently, advanced prostate cancer. In the United States, patient access to this therapy is currently variable. Implementation of new RLT programs and expansion of existing programs are needed to broaden patient access to and standardize the delivery of RLT, especially as new therapies are introduced into clinical practice. Drawing from experience in establishing RLT programs in different settings, we have developed practical recommendations for building and implementing a robust RLT program. In this review, we present our recommendations for minimal requirements and optimal requirements, as well as system considerations, and special issues associated with implementing an RLT program in North American centers.

show abstract

Section: Methods and Guidance For Building A Robust Rlt Programmentioning

confidence: 99%

Section: Methods and Guidance For Building A Robust Rlt Programmentioning

confidence: 99%

Section: Authorized Usermentioning

confidence: 99%

Section: Authorized Usermentioning

confidence: 99%

See 2 more Smart Citations

Establishing a robust radioligand therapy program: A practical approach for North American centers

Mittra,

Wong,

Winters

et al. 2024

Cancer Medicine

View full text Add to dashboard Cite

show abstract

“…This is a physician who has been certified in the relevant specialty by a medical board recognized by the US NRC or who meets a specific combination of training and work experience in this specialty. More details on the requirements for authorized users are provided by Baldwin et al (2015) .…”

Section: Radiation Safety Programmentioning

confidence: 99%

Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy

et al. 2022

View full text Add to dashboard Cite

Importance 177 Lu therapy as part of theranostic treatment for cancer is expanding but it can be a challenge for sites with limited radiation protection staff to implement the radiation safety program required for therapeutic nuclear medicine. Objective To increase the adoption of 177 Lu therapy, especially in smaller centers and clinics, by providing a collection of radiation safety best practices and operational experience. To provide a resource for radiation safety officers supporting the implementation of a 177 Lu therapy program. Methods A panel of 11 radiation safety professionals representing sites across Canada and the United States with experience delivering 177 Lu therapy was assembled and discussed their responses to a list of questions focused on the following radiation safety topics: facility layout and design; radiation safety program; and drug management and patient care. Results A comprehensive set of best practice guidelines for clinical radiation safety during 177 Lu therapy has been developed based on the collective operational experience of a group of radiation safety professionals. Significant findings included that 177 Lu therapy is often safely administered in unshielded rooms, that staff radiation exposure associated with 177 Lu therapy is minimal relative to other nuclear medicine programs, and that some relatively simple preparation in advance including papering of common surfaces and planning for incontinence can effectively control contamination during therapy. Conclusion The guidance contained in this paper will assist radiation safety professionals in the implementation of safe, effective 177 Lu therapy programs, even at smaller sites with limited to no experience in therapeutic nuclear medicine.

show abstract